Stock Scorer

Cardio Diagnostics Holdings, Inc. (CDIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 6K 12K 18K Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 950 Q1 '23: 0 Q2 '23: 1.7K Q3 '23: 10K Q4 '23: 5.3K Q1 '24: 15.9K Q2 '24: 7.9K Q3 '24: 6.6K Q4 '24: 4.5K Q1 '25: 940 Q2 '25: 7.5K Q3 '25: 2.9K Q4 '25: 3.6K Q1 '26: 2.7K Q2 '26: 5.4K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -324 Q4 '21: -144.6K Q1 '22: -227.1K Q2 '22: -787K Q3 '22: -1.2M Q4 '22: -2.4M Q1 '23: -1.7M Q2 '23: -2.6M Q3 '23: -1.4M Q4 '23: -1.5M Q1 '24: -4.2M Q2 '24: -1.3M Q3 '24: -1.4M Q4 '24: -1.5M Q1 '25: -1.6M Q2 '25: -1.7M Q3 '25: -1.7M Q4 '25: -1.5M Q1 '26: -1.8M Q2 '26: -1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -324 Q4 '21: -144.1K Q1 '22: -290.1K Q2 '22: -842K Q3 '22: -1.2M Q4 '22: -2.4M Q1 '23: -1M Q2 '23: -4M Q3 '23: -1.9M Q4 '23: -1.4M Q1 '24: -4.2M Q2 '24: -1.3M Q3 '24: -1.4M Q4 '24: -1.5M Q1 '25: -1.6M Q2 '25: -1.7M Q3 '25: -1.7M Q4 '25: -1.5M Q1 '26: -1.8M Q2 '26: -1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -174 Q4 '21: -300.8K Q1 '22: -186.1K Q2 '22: -394.8K Q3 '22: -1.4M Q4 '22: -3.1M Q1 '23: -1.6M Q2 '23: -1.3M Q3 '23: -1M Q4 '23: -1.7M Q1 '24: -1.2M Q2 '24: -1.2M Q3 '24: -1.2M Q4 '24: -1.4M Q1 '25: -1.4M Q2 '25: -1.6M Q3 '25: -1.4M Q4 '25: -1.4M Q1 '26: -1.6M Q2 '26: -1.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q3 '22: -1.4M Q3 '23: -1.1M Q4 '23: -2.2M Q1 '24: -1.3M Q2 '24: -1.4M Q3 '24: -1.2M Q4 '24: -1.4M Q1 '25: -1.4M Q2 '25: -1.6M Q3 '25: -1.6M Q4 '25: -1.4M Q1 '26: -1.6M Q2 '26: -1.3M Q3 '22 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q1 '22: 4.2M Q2 '22: 5.4M Q3 '22: 6.6M Q1 '23: 9.5M Q2 '23: 10.2M Q3 '23: 11.9M Q1 '24: 702.6K Q2 '24: 753.6K Q3 '24: 814.8K Q1 '25: 1.7M Q2 '25: 1.7M Q3 '25: 1.8M Q1 '26: 2.8M Q2 '26: 3M Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q4 '22: -1.49 Q1 '23: -1.53 Q2 '23: -1.76 Q3 '23: -1.75 Q4 '23: -0.66 Q1 '24: -6.48 Q2 '24: -7.80 Q3 '24: -9.37 Q4 '24: -9.65 Q1 '25: -4.69 Q2 '25: -3.95 Q3 '25: -3.20 Q4 '25: -3.72 Q1 '26: -3.38 Q2 '26: -2.92 Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for CDIO: Gross Profit, Cost of Revenue. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.